Cadila Healthcare informs about press release

01 Mar 2016 Evaluate

Cadila Healthcare has informed about a Press Release dated March 01, 2016 titled ‘Zydus receives final approval from the USFDA for Glyburide and Metformin Hcl Tablets USP’.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

913.90 -7.35 (-0.80%)
16-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1782.80
Dr. Reddys Lab 1279.00
Cipla 1500.00
Zydus Lifesciences 913.90
Lupin 2089.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×